US › Healthcare

Stereotaxis Inc (STXS)

US · Healthcare · Medical Instruments & Supplies

$1.09+3.81%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$7.7M

Revenue YoY

-12.8%

Net profit

$-4.5M

EPS

$-0.05

EPS estimate

$-0.03

Net margin

-58.3%

EPS came in at -0.05 against a street estimate of -0.03 — a miss of 66.7%.

Key statistics

Market cap

$105.2M

Forward P/E

19.6

P/B

7.83

Book value

$0.12

EPS (TTM)

$-0.24

52-week high

$2.89

52-week low

$0.80

50-day MA

$1.19

200-day MA

$1.68

Beta

1.40

Analyst view

Analysts rate Stereotaxis Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $3.00.

Shareholding

Insiders

15.20%

Institutions

48.81%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Stereotaxis Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.